Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting serine proteases in asthma.

Caroline Guay1, Michel Laviolette, Guy M Tremblay

  • 1Unité de Recherche, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, Sainte-Foy, Quebec, Canada G1V 4G5.

Current Topics in Medicinal Chemistry
|April 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The clinical value and most informative threshold of polygenic risk score in the Quebec City Case-Control Asthma Cohort.

BMC pulmonary medicine·2025
Same author

S100A alarmins and thymic stromal lymphopoietin (TSLP) regulation in severe asthma following bronchial thermoplasty.

Respiratory research·2023
Same author

Bronchial thermoplasty attenuates bronchodilator responsiveness.

Respiratory medicine·2023
Same author

The reduction of airway smooth muscle by bronchial thermoplasty stands the test of time.

ERJ open research·2023
Same author

Human and Mouse Eosinophils Differ in Their Ability to Biosynthesize Eicosanoids, Docosanoids, the Endocannabinoid 2-Arachidonoyl-glycerol and Its Congeners.

Cells·2022
Same author

Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study.

Chest·2021

Asthma involves serine proteases from lung cells. This review highlights new inhibitors targeting these proteases, offering potential therapeutic advancements for asthma treatment.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Leukocytes and lung structural cells produce serine proteases implicated in asthma pathophysiology.
  • Key proteases include mast cell tryptase/chymase, neutrophil elastase, and granzyme B.

Purpose of the Study:

  • To review promising serine protease inhibitors in the asthma research and development pipeline.
  • To discuss endogenous and non-human derived compounds as potential therapeutic agents.

Main Methods:

  • Literature review of current research and development in serine protease inhibitors for asthma.
  • Analysis of non-peptidic inhibitors targeting specific asthma-related proteases.

Main Results:

  • Several potent and selective inhibitors, primarily non-peptidic, are in development.

Related Experiment Videos

  • Focus is on inhibitors targeting mast cell tryptase and chymase.
  • Endogenous inhibitors and compounds from other species are also under investigation.

    • Conclusions:

    • Development of novel serine protease inhibitors shows promise for asthma therapy.
    • Targeting specific proteases offers a potential strategy to modulate asthma pathophysiology.